Silenor
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Silenor (doxepin) is a tricyclic antidepressant. It inhibits the reuptake of serotonin and norepinephrine and possesses…
In older patients with primary insomnia, Silenor can increase duration of sleep without next-day effects. However, it does not…
New Formulation: Doxepin (Silenor) was approved in March 2010 for the treatment of insomnia.